T he purpose of this 2-part review is to explore the ability of cells and organisms to survive, and in some cases thrive, in hostile hypoxic environments and to identify common themes that may have therapeutic applications for humans subjected to hypoxic or oxidative stress. The first part of this review outlined the similarities between embryogenesis, mammalian adaptation to hypoxia (including hibernation and diving adaptations), the role of reactive oxygen species (ROS) in ischemia-reperfusion injury, the ability of cancer cells to survive in oxygen-poor environments, and the energetic derangements that occur during uncontrolled infection and inflammation. The second part of this review focuses on technology that may allow investigators and clinicians to gain real-time insight into subcellular energetics, as well as describes potential treatment modalities that, based on this information, could be used to specifically target and modify the subcellular energetic machinery.
T he purpose of this 2-part review is to explore the ability of cells and organisms to survive, and in some cases thrive, in hostile hypoxic environments and to identify common themes that may have therapeutic applications for humans subjected to hypoxic or oxidative stress. The first part of this review outlined the similarities between embryogenesis, mammalian adaptation to hypoxia (including hibernation and diving adaptations), the role of reactive oxygen species (ROS) in ischemia-reperfusion injury, the ability of cancer cells to survive in oxygen-poor environments, and the energetic derangements that occur during uncontrolled infection and inflammation. The second part of this review focuses on technology that may allow investigators and clinicians to gain real-time insight into subcellular energetics, as well as describes potential treatment modalities that, based on this information, could be used to specifically target and modify the subcellular energetic machinery.
ASSESSMENT OF SUBCELLULAR ENERGETIC STATE
Given the central role of the mitochondria in survival under "normal" conditions as well as during adaptation to stress, a logical approach to evaluating subcellular energetics would be to assess the individual mitochondrial pathways involved in energy production. Several techniques have been proposed for this purpose: P 31 nuclear magnetic resonance (NMR) spectroscopy to measure high-energy phosphates, near-infrared spectroscopy (NIRS) to measure the oxidation state of cytochrome aa3, the protoporphyrin IX-triplet state lifetime technique (PpIX-TSLT) approach for measurement of mitochondrial Po 2 , and serum lactate measurements to gauge anaerobic energy production ( Figure 1 ).
P 31 Nuclear Magnetic Resonance Spectroscopy
NMR spectroscopy takes advantage of the fact that magnetic nuclei exist in a finite number of energy states, also referred to as "spin" states, that application of electromagnetic radiation (EMR) in the radio frequency (RF) range can impart energy to nuclei and move them between spin states, and that transition from a higher to lower energy spin state leads to emission of detectable radio waves. 1 Performance of NMR thus involves aligning spin states through the application of a magnetic field, increasing the energy state of specific magnetic nuclei using RF-EMR, and detecting the resulting RF-EMR emitted when the magnetic nuclei return to their baseline state. The resulting EMR is referred to as free induction decay, which has 4 components: amplitude or intensity, frequency, phase, and half-life. 1 These 4 spectroscopic features can then be used to identify and quantify specific compounds that have a unique NMR "fingerprint." In addition, because various environmental factors affect the behavior of magnetic nuclei, information about the surroundings and activity of certain compounds may also be derived. 1 Although H 1 , C 13 , and Na 23 are biologically relevant and can all be interrogated, P 31 NMR is particularly useful to biomedical researchers because it can measure the concentration of phosphocreatine, adenosine triphosphate (ATP), and inorganic phosphate (Pi), in addition to measuring intracellular pH based on the frequency shift associated with Pi that is caused by alterations in pH. 2 Advantages of P 31 NMR include the noninvasive nature of the technique and the wealth of information that can be derived. The primary disadvantages of P 31 NMR are the requirement for large, magnetically isolated, expensive equipment, as well as the relatively long acquisition time, the latter of which precludes acquisition of continuous data. Furthermore, these traits have limited P 31 NMR to research use exclusively, and Part I of this review discussed the similarities between embryogenesis, mammalian adaptions to hypoxia (primarily driven by hypoxia-inducible factor-1 [HIF-1]), ischemia-reperfusion injury (and its relationship with reactive oxygen species), hibernation, diving animals, cancer, and sepsis, and it focused on the common characteristics that allow cells and organisms to survive in these states. Part II of this review describes techniques by which researchers gain insight into subcellular energetics and identify potential future tools for clinicians. In particular, P 31 nuclear magnetic resonance to measure high-energy phosphates, serum lactate measurements, the use of near-infrared spectroscopy to measure the oxidation state of cytochrome aa 3 , and the ability of the protoporphyrin IX-triplet state lifetime technique to measure mitochondrial oxygen tension are discussed. In addition, this review discusses novel treatment strategies such as hyperbaric oxygen, preconditioning, exercise training, therapeutic gases, as well as inhibitors of HIF-1, HIF prolyl hydroxylase, and peroxisome proliferator-activated receptors. (Anesth Analg 2017;124:1872-85) clinical applications are not forthcoming. As described in Part I of this review, P 31 NMR has been used extensively to understand the impact of sepsis and uncontrolled inflammation on subcellular energetics by analyzing both ATP levels and intracellular pH.
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Serum Lactate Measurements
In the setting of inadequate mitochondrial oxygen supply, hypoxia-inducible factor 1 (HIF-1) activates lactate dehydrogenase-A, converting pyruvate to lactate and depriving the tricyclic acid cycle of Acetyl-CoA. 9, 10 This response is part of a complex "metabolic switch" designed to transition cells away from oxidative phosphorylation so that energy production can continue in a relatively hypoxic environment. 11 Thus, lactate production may be a sign of inadequate oxygen supply. Traditionally, lactate elevation has been almost universally ascribed to inadequate oxygen delivery. 12 Lactate production can also be upregulated by a variety of nonhypoxic stimuli including mitochondrial ROS (which also upregulate HIF-1) [13] [14] [15] [16] as well as endogenous β2-adrenergic stimulation. 12 Lactate is an alternative fuel source and can improve cardiovascular function in various pathologic states. [17] [18] [19] Elevated serum lactate has been shown to be a marker for increased mortality in patients undergoing both cardiac and noncardiac surgery, 20, 21 and normalization of lactate has been associated with improved mortality in sepsis. 22 A multicenter, randomized controlled trial (RCT) comparing lactate-guided resuscitation to standard of care in septic shock showed a significantly lower mortality in the lactate-guided group, although there were no significant differences in lactate levels between groups. 23 A similarly sized trial comparing ScvO 2 to lactate-guided treatment in sepsis found no difference between groups and concluded that lactate was noninferior to ScvO 2 -guided therapy. 24 Interestingly, the combination of lactate and ScvO 2 in a large, single-center RCT of patients undergoing cardiac surgery demonstrated decreased length of stay and reduced organ failure in the treatment group but, as in the Jansen trial, no differences were found in lactate or ScvO 2 between groups. 25 Combined, these data suggest that lactate may be a useful guide for therapy, although larger trials in which serum lactate levels differ between groups are needed to rigorously assess the utility of this diagnostic tool.
In the absence of definitive clinical data, the understanding that lactate production can be attributable to hypoxia, ROS production, or β2-adrenergic stimulation, the fact that serum lactate is a global marker and provides no regional or organ-specific information, and the fact that lactate is an energy source that may improve cardiac function make the rational use of this incompletely understood global marker difficult. Although elevated serum lactate may signify a problem, additional information is needed to determine whether and where such a problem exists.
Near-Infrared Spectroscopy
The NIRS approach is based on the Beer-Lambert principle: because biological compounds ("chromophores") have unique absorption profiles, tissue absorption of light can be used to calculate the relative concentration of each chromophore. This calculation is performed by inverting a matrix of the absorption coefficients for each species and generating a series of linear equations describing concentration in terms of absorbance at each wavelength. 26 A clinical example of chromophore analysis is pulse oximetry, in which 2 wavelengths (red, infrared) are utilized to measure the concentrations of oxyhemoglobin and deoxyhemoglobin. Because 1 wavelength of light is required for each chromophore, a 2-wavelength pulse oximeter cannot measure additional chromophores, such as carboxyhemoglobin, or methemoglobin ( Figure 2) . NIRS was developed originally to assess the oxidation state of cytochrome aa 3 , the terminal component of the electron transport chain (ETC). 26 When oxygen is Figure 1 . Four techniques for assessing the state of subcellular energetics (in yellow). P 31 NMR can measure the concentration of ATP (and also intracellular pH) in both intact animals and tissue, but it requires expensive, bulky equipment and cannot provide continuous measurements. Broadband NIRS can assess the oxidation state of cytochrome aa 3 , the terminal component of the electron transport chain and the enzyme that adds protons from the mitochondrial matrix and electrons from the electron chain to molecular oxygen, producing water. This technique requires advanced spectroscopy equipment but is noninvasive and can be performed at the bedside. Lactate is a byproduct of anaerobic metabolism and, although produced by the mitochondria when oxygen supplies diminish, it can be easily measured in the serum. The protoporphyrin IX-triplet state lifetime technique can measure mitochondrial oxygen levels and can also be performed at the bedside. ATP indicates adenosine triphosphate; NIRS, near-infrared spectroscopy; NMR, nuclear magnetic resonance.
www.anesthesia-analgesia.org ANESTHESIA & ANALGESIA supplied to the cell, it enters the mitochondria and accepts electrons from the ETC in a fashion that produces energy. Cytochrome aa 3 mostly exists in an oxidized state. When oxygen is not available, does not enter the mitochondria, or electron transfer is interrupted, cytochrome aa 3 is reduced, and its change in absorbance spectrum is detectable using NIRS. Thus, unlike estimates of "tissue oxygen saturation" based on hemoglobin, the oxidation state of cytochrome aa 3 provides information about the redox state of the mitochondria themselves.
Measuring the oxidation state of cytochrome aa 3 (Cyt ox ) is challenging for several reasons. Cytochromes are present in lower concentrations than hemoglobin and absorb less near-infrared radiation, effectively lowering the signal-to-noise ratio. To increase the accuracy of cytochrome measurements (overall, the cytochromes are responsible for less than 10% of near infrared absorbance), "broadband" techniques that use a "band" of red and infrared light incorporating more than 100 wavelengths have been developed. [27] [28] [29] [30] The ability of broadband NIRS to accurately quantify changes in Cyt ox in vivo was convincingly demonstrated by Cooper et al, 31 who used sodium cyanide to manipulate the redox state of cytochrome aa 3 independent of hemoglobin, and Lee et al, 32 who found a simultaneous increase in StO 2 and reduction in of cytochrome aa 3 in a rabbit model after NaCN injection (Figure 3) . Using a rat model, my laboratory has reported similar results. 32a The clinical utility of Cyt ox is predicated on the belief that oxygen may not always diffuse out of the blood stream, into cells, and into the mitochondria for use in oxidative phosphorylation. For instance, animal experiments have demonstrated discrepancies between StO 2 and Cyt ox during cooling in preparation for deep hypothermic circulatory arrest. 33 Furthermore, broadband NIRS has demonstrated reductions in Cyt ox with normal StO 2 levels up to 10 hours after application of experimental hypoxia and ischemia, 34 consistent with magnetic resonance spectroscopy studies suggesting that injury occurs hours after an ischemic insult. 35 Figure 2. Graphical depiction of how near-infrared radiation can be used to calculate chromophore concentrations using the Beer-Lambert principle. In this example, a 6 wavelength device is used to measure 3 chromophore concentrations (X, Y, and Z). A light source (A) produced light at various wavelengths, which enters tissue (a). Transmitted light (b) is carried to a spectrometer (B), which sends the information to a laptop computer (C). Based on measurements of the emitted and detected light, absorbance (and optical density) can be calculated, which, when combined with known spectral data for compounds X, Y, and Z, can estimate the concentration of each.
Porphyrins are common biological macromolecules made of 4 pyrrole subunits, the best known of which are hemoglobin and chlorophyll. The cyclic shape of porphyrins allows them to conjugate with metallic ions, for example, iron (hemoglobin) or magnesium (chlorophyll), and these ions give them their unique properties. Most porphyrins absorb light in the visible range of the spectrum, leading to excitation of the porphyrin-metal complex. 123 Understanding how PpIX-TSLT can be used to measure oxygen concentrations requires a brief detour into quantum mechanics. Elementary particles can be described by classical angular momentum (an example is an electron orbiting around a proton) but also by intrinsic angular momentum, or rotation around an internal axis. Most molecules exist in a "paired-spin" arrangement, in which parallel and antiparallel (paired) spins cancel each other out. This state is also referred to as a "singlet state," and the total spin is 0. When the angular momenta of 2 parallel (ie, not paired) spins are added, the result is non-zero total spin, and this is described as a "triplet state." 38 Molecular oxygen is unique in that it exists primarily in a triplet state at room temperature.
Interestingly, although most porphyrins remain in singlet states even when excited, they can transition to a triplet state (eg, T 1 ) through either internal conversion or intersystem crossing. A porphyrin molecule in a triplet state can then revert back to a singlet state through spontaneous relaxation or collision with an oxygen molecule, in which oxygen absorbs the extra energy of the porphyrin and transitions from the normal, triplet state to a higher energy singlet state. The latter process is referred to as "triplet state quenching" and is a function of oxygen concentration. Triplet state quenching leads to both phosphorescence and delayed fluorescence, thus measurement of phosphorescence and/or delayed fluorescence can inform the triplet state lifetime (τ), the rate constant describing triplet state quenching (k), and therefore oxygen concentrations. 123 Practically speaking, τ, k, and pO 2,mito are measured by introducing 5-aminolevulinic acid ([ALA] a porphyrin precursor that increases mitochondrial protoporphyrin IX concentrations), pulsing a green (510 nm) light into tissue, and detecting the delayed fluorescent signal (630-700 nm). In mitochondria with high levels of oxygen, triplet state quenching will occur quickly, and fluorescence will decline rapidly ( Figure 4 ). Using a rodent lipopolysaccharide (LPS) injection model, Harms et al demonstrated reduced mitochondrial pO 2 in the setting of sepsis and improvements in mitochondrial pO 2,mito with fluid resuscitation. 124 More recently, Römers et al 39 found that during progressive hemodilution in pigs, decreases in mitochondrial pO 2 preceded alterations in global hemodynamics, lactate, and StO 2 .
THERAPEUTIC APPLICATIONS TARGETING SUBCELLULAR ENERGETICS
A more comprehensive (albeit still incomplete) understanding of how cells adapt to oxygen-poor environments and of the crucial role of ROS/reactive nitrogenous species in various pathologic states may allow researchers and clinicians to design novel therapeutic modalities that move beyond the first order macroscopic approaches of maintaining adequate cardiac output, oxygen carrying capacity, and hemoglobin saturation. In particular, the measurement techniques described above may alert clinicians to previously invisible life-threatening perturbations in subcellular energetics that may, in some cases, be modifiable using the strategies that follow.
Hyperbaric Oxygen Therapy
An early trial of hyperbaric oxygen (HBO) in a polymicrobial rodent sepsis model found a reduction in mortality despite higher levels of bacteria in the bloodstream in the HBO group, suggesting that the mortality reduction was not related to improved antimicrobial efficacy. 40 Lin et al 41 tested HBO and aminoguanidine (an NO synthase inhibitor) in septic rats using the LPS infusion model. They found that although HBO did not affect nitric oxide production, superoxide production, or tumor necrosis factor α (TNF-α) levels in healthy animals, HBO decreased plasma nitric oxide, aortic superoxide, and TNF-α levels in animals exposed to LPS, in addition to improving mortality. Notably, septic animals treated with aminoguanidine had similar plasma NO www.anesthesia-analgesia.org ANESTHESIA & ANALGESIA and TNF-α levels to those treated with HBO, but they had higher levels of aortic superoxide anion and experienced no mortality benefit. 41 This suggests that superoxide production in the setting of uncontrolled infection may be particularly harmful.
The results of more recent trials using higher amounts of HBO have been mixed. A mouse model of sepsis found a survival benefit at 2.5 ATM (every 12 hours) but worsened outcomes with 3.0 ATM (every 24 hours). 42 In this case, HBO did show an antibacterial effect, with fewer colony forming units found in the spleen (but not the peritoneal fluid) of animals subjected to 2.5 ATM. The authors hypothesized that higher levels of HBO may have led to oxygen toxicity because signs of injury have previously been shown at 3 ATM. 43 Other recent trials in a variety of animal models (rodents and equine) have also not found benefit. 44, 45 HBO has also been proposed as a treatment to improve neurologic function after stroke. Preclinical work suggests that HBO may attenuate inflammation, stimulate neurogenesis, and inhibit apoptosis after stroke. 46, 47 An analysis of delayed HBO therapy (2.5 ATM) on neurologic recovery after middle cerebral artery occlusion showed improved neurologic function at 42 days. An increase in ROS and HIF-1 were observed in the HBO group, suggesting both that HBO can increase ROS and that elevated ROS levels can upregulate HIF-1 in the absence of hypoxia (as described above [13] [14] [15] [16] [48] [49] [50] ). Repeated, high doses of HBO (5 ATM) are neurotoxic, likely because of upregulation of neuronal NOS and the presence of increased ROS/reactive nitrogenous species. 51 HBO levels as low as 3 ATM increase NO formation in rat brains. 52 In an effort to determine which ROS were responsible for the neurotoxicity associated with HBO, Oury et al 53 subjected animals to 6 ATM HBO. Using a combination of transgenic mice able to overexpress extracellular superoxide dismutase (ECSOD), and inhibitors of both ECSOD and NO synthase, they found that NO overexpression was the most likely cause of HBO-mediated cellular toxicity, and that O 2 − may have a protective role by inactivating NO. 53 This finding conflicts with the sepsis model of Lin et al 41 that suggested that O 2 − was primarily responsible for the injury that accompanies sepsis, although the mechanisms of organ injury accompanying LPS infusion and 6 ATM HBO may be quite different. 41 The role of HBO as a cardioprotectant has also been explored, primarily because of its potential to interact with NOS. In a rodent model of cardiac ischemia (25 minutes) and reperfusion (180 minutes), HBO was found to be cardioprotective. Interestingly, HBO increased endogenous nitrate/nitrite, and the cardioprotective effect of HBO was reversed by pretreatment with the NOS inhibitor N(G)-nitro-L-arginine methyl ester, strongly suggesting that NO production attributable to HBO had protective effects. 54 Small human studies using HBO to precondition the myocardium before coronary artery bypass grafting (CABG) surgery have consistently demonstrated reduced perioperative troponin release in addition to clinical benefits. 55, 56 Effective use of HBO may thus require identifying a "sweet spot," where HBO increases oxygen delivery to the ETC, upregulates HIF-1 through ROS-mediated mechanisms, and attenuates inflammation, but beyond which ROS production may cause oxygen toxicity. Real-time techniques designed to interrogate the subcellular redox state (described above) may be useful in the titration of this both helpful and harmful treatment modality. Figure 4 . A, Graphical depiction of the PpIX-TSLT. 5-ALA, a porphyrin precursor that increases mitochondrial protoporphyrin IX concentrations, is applied topically. A green (510 nm) excitation pulse passes into tissue, exciting the porphyrin-metal complex. Delayed fluorescence is a function of oxygen concentrations and is detected at 630 to 700 nm wavelength. B, A collision between oxygen and a porphyrin in a triplet state will sometimes transfer energy to the oxygen, which then transitions into a triplet state. This is referred to as triplet state quenching and leads to phosphorescence and delayed fluorescence, both of which are detectable and allow for the estimation of Po 2 in tissue. 37 57 demonstrated that multiple, brief ischemic episodes could "prepare" a tissue bed (in this case, canine myocardium) for a more significant ischemic insult. This observation gave birth to the concept of "ischemic preconditioning," which was followed by pharmacologic (eg, anesthetic) and other forms of preconditioning. 57, 58 Multiple groups have explored the genomic and proteomic changes that occur after ischemic and anesthetic preconditioning and have found significant overlap, suggesting that the underlying mechanisms may be similar. 59, 60 Common elements include upregulation in genes/proteins that control glycolysis, mitochondrial respiration, and the stress response. More specifically, preconditioning is mediated by nitric oxide synthase, [61] [62] [63] activity of ATP-sensitive potassium (K ATP ) channels, [64] [65] [66] opening of the mitochondrial permeability transition pore, 67, 68 and maintenance of calcium homeostasis/avoidance of calcium overload, 69-71 among other mechanisms.
Growing evidence suggests that HIF-1 plays an important, and in some cases, essential role in the development of ischemic or hypoxic preconditioning.
72-78 HIF-1 may even play a role in the induction of pharmacologic preconditioning (at least with isoflurane). [79] [80] [81] In addition to the roles for HIF-1 described in Part 1 of this review, HIF-1 may modulate both apoptosis and the inflammatory response to ischemia and, in doing so, induce organ protection after ischemia. 82 NO produced in response to HIF-1-mediated iNOS upregulation 78 also plays a prominent role in preconditioning. During ischemia, NO begins to accumulate (despite the relative lack of oxygen), eventually leading to an oversupply of ROS which, when coupled with a sudden increase in oxygen during reperfusion, cause peroxynitrate production and tissue injury. 83 However, brief, repetitious periods of ischemia modulate subsequent NO production and peroxynitrate formation, attenuating injury after more prolonged ischemic periods. This protective process can be reversed with NOS inhibition, suggesting a direct causal link between NO production and preconditioning. 78, 84 In addition, studies indicate that although NO inhibition can completely block preconditioning, addition of l-arginine (a NOS substrate) can reverse this inhibition, cementing the critical role of NO in the development of preconditioning. 85 NOS can thus be both helpful (inducing preconditioning after exposure to transient periods of ischemia) and harmful (leading to NO and peroxynitrate production).
Preconditioning appears also be dependent on stimulation of NMDA receptors by glutamate: in cells pretreated with NMDA-antagonists, hypoxic preconditioning is abolished, and exposure of preconditioned cells to excitotoxins still results in cell death. These data suggest that hypoxic preconditioning, through glutamate-mediated NMDAagonism, may attenuate the release of excitotoxic agents after subsequent cellular stress. 86 The suggestion that NMDA receptors are implicated in the development of preconditioning is also supported by demonstrations that preconditioning produces moderate increases intracellular calcium concentrations and multiple demonstrations that treatment with NMDA antagonists can suppress the effects of preconditioning. 85, 87, 88 Furthermore, inositol phosphoceramide can be prevented through attenuation of ε-PKC, and reactivated through administration of diacylglycerol analogs, suggesting that although calcium accumulation likely plays a role in development of inositol phosphoceramide, calcium-independent mechanisms are also involved. 88 Preconditioning and postconditioning (therapy is induced during reperfusion) have been primarily utilized to protect against ischemic insults. An early, small study of postconditioning showed a reduction in infarct size after angioplasty in humans. 89 Multiple investigators attempted to utilize preconditioning and postconditioning to attenuate myocardial injury in the setting of myocardial infarction, and although the data are mixed, an overall benefit is likely. 90 Outside the catheterization laboratory, preconditioning the myocardium directly is a challenge. Interest in remote ischemic preconditioning, in which ischemia of another tissue bed (eg, muscle) confers protective benefits on tissues not subjected to ischemia was generated by a demonstration of reduced myocardial injury and all-cause mortality in patients undergoing CABG surgery and a similar trial finding less kidney injury in patients undergoing cardiac surgery. 91, 92 However, enthusiasm for remote ischemic preconditioning was subsequently tempered by 2 large, multicentered RCTs showing no benefit in patients undergoing CABG surgery. 93, 94 The underlying mechanistic similarities between cellular injury that accompanies ischemia and inflammation have prompted investigators to study preconditioning in sepsis. Olguner et al 95 subjected rats with and without ischemic preconditioning to experimental sepsis and found that ischemic preconditioning led to less kidney injury, lower lung macrophage counts, and decreased lung and kidney injury scores. Two subsequent preclinical trials found decreased markers of inflammation (TNF-α), reduced abscess formation, 96 and increased survival (possibly heme oxygenase-1 mediated) in animals subjected to preconditioning before sepsis. 97 
Exercise Training
Physicians have long appreciated that patients who are "physically fit" are more likely to survive anesthesia and surgery than those who are not. This observation is based on a relatively large body of work suggesting that quantitative measures of fitness (eg, maximal VO 2 and aerobic threshold) predict morbidity and mortality after a variety of major surgical procedures ( Figure 5) . [98] [99] [100] [101] [102] [103] [104] [105] [106] This phenomenon is not limited to surgical insults because studies suggest that patients who report recent physical activity are more likely to survive myocardial infarction than those who do not. 107 Of the cardiopulmonary exercise testing variables available, aerobic threshold and maximal VO 2 are the best validated. 108 Despite the great promise of cardiopulmonary exercise testing for discriminating between survivors and nonsurvivors and major surgery, 2 large questions remain. First, why does exercise tolerance confer a benefit in patients undergoing surgery? And second, can exercise be used as a therapeutic modality in patients who anticipate exposure to surgery or other forms of stress?
The epidemiologic connection between vigorous exercise and reduced cardiac morbidity in humans has led several investigators to elucidate the molecular impact of exercise www.anesthesia-analgesia.org ANESTHESIA & ANALGESIA training on specific organ systems, in particular, the cardiovascular system. [109] [110] [111] Multiple groups have demonstrated that exercise training protects animal hearts from ischemiareperfusion injury both by attenuating the reduction in function that accompanies ischemia and by improving postreperfusion function. [112] [113] [114] Interestingly, trained animals exhibit increased concentrations of nonprotein thiols and glutathione, increased superoxide dismutase activity and increased levels of lactate dehydrogenase, suggesting a role of antioxidants as well as anaerobic metabolism in organ protection. 112, 114 Both superoxide dismutase and glutathione are correlated with ventricular function after injury, strongly implicating a role for antioxidant activity in preservation of function. 114 Of all the potential mechanisms by which exercise training has been shown to induce organ protection, enhanced antioxidant activity is best supported by evidence. 112, [115] [116] [117] [118] [119] [120] [121] Both age and obesity attenuate the beneficial effects of preconditioning. Interestingly, exercise therapy preserves the preconditioning effect of both ischemia and anesthetic administration in senescent and obese animals. 113, 122 The relationship between exercise training and preconditioning has led investigators to seek out shared mechanisms of organ protection. For instance, NOS expression and ROS are known to play prominent roles in preconditioning. Although not all studies show an effect on NOS expression after exercise training, [123] [124] [125] most studies suggest that exercise leads to endothelial, neuronal, or inducible NOS upregulation. [126] [127] [128] [129] [130] [131] [132] [133] [134] However, because of differences in the animal model, type of exercise, and tissue bed(s) examined, it is not yet possible to make definitive conclusions about the impact of exercise training on NOS production in humans. Similarly, some (but not all 135 ) studies that focused on ROS production in animal myocardium (as opposed to antioxidant expression) have suggested that exercise training attenuates ROS production during injury. 136, 137 Exercise training can lead to local hypoxia, with tissue PaO 2 levels as low as 3 mm Hg (similar to those seen in hypoxia or ischemia). 138 Thus, one might expect HIF-1 activation during exercise training, and indeed, both exercise and muscle stimulation stabilize HIF-1 and increase vascular endothelial growth factor (VEGF) expression. [139] [140] [141] After longer periods of training (eg, 4 to 8 weeks), the increase in HIF-1α and VEGF expression after acute exercise are attenuated, suggesting that chronic exercise reduces local hypoxia and/or the production of ROS (both of which can lead to HIF-1α stabilization and subsequent VEGF expression). 142, 143 Recognition that exercise training leads to mechanical, metabolic, and oxidative stress that produces downstream adaptations similar to those seen in classical ischemic preconditioning eventually led to the term "exercise preconditioning." 144 In addition to antioxidant protection, HIF-1α stabilization, VEGF expression, and possibly NOS expression, exercise may also lead to angiogenesis, enhanced expression of neurotrophin and thromboxane, and increased production of myocardial antiapoptotic proteins and a reduction in ROS-induced cytochrome c release from mitochondria. [145] [146] [147] Not surprisingly, attempts have been made to utilize exercise therapy for the prevention of organ injury after a variety of insults. Multiple studies have demonstrated reduced infarct volumes, and in some cases, improved survival in exercise-trained animals subjected to stroke. 146, 148, 149 Exercise therapy has also been tested in animals subjected to experimental sepsis, with trained animals demonstrating higher blood pressure, lower heart rate, and less pulmonary injury than untrained animals. 150 Recent work has suggested that quantifiable measures of fitness can be improved in the weeks leading up to elective surgery. Exercise therapy may thus be a viable preemptive treatment option for patients expecting to be subjected to significant stress in the near future (eg, elective surgical procedures).
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Therapeutic Gases
Nitric oxide (NO), hydrogen sulphide (H 2 S), and carbon monoxide (CO) are gasotransmitter molecules that have specific biological functions, some of which are adaptive and some of which are potentially harmful. 83 NO is a well-established regulator of both endothelial function and vascular tone. It has multiple known biological targets, including soluble guanylate cyclase, hemoglobin, and several cytochromes. In addition, NO leads to the production of nitrite, nitrate, peroxynitrite, and S-nitrosothiols. Beyond its effects on the vascular smooth muscle and endothelium, NO is known to attenuate ischemia-reperfusion injury. 153 These effects are thought to be mediated by actions on the mitochondria. For instance, nitrite can nitrosate complex I of the ETC, limiting mitochondrial ROS production during hypoxia and potentially decreasing cytochrome c release. 154 NO also directly inhibits the ETC, reducing energy production and ROS formation, the latter of which may limit apoptotic signaling. 155 In a small human trial, inhaled NO (80 ppm) was shown to attenuate hepatic ischemia-reperfusion injury during liver transplantation. 156 Figure 5 . In patients subjected to CPET before major surgery, those who fail to meet population-based activity thresholds (eg, VO 2 at aerobic threshold, peak VO 2 , and the ventilatory equivalent ratio for carbon dioxide) are less likely to survive. CPET indicates cardiopulmonary exercise testing.
H 2 S is produced endogenously by several enzyme systems, including 3-mercaptopyruvate sulphurtransferase, cystathionine γ-lyase, and cystathionine β-synthase.
83 H 2 S acts on both ion channels and several signaling proteins. 83 Like NO, H 2 S appears to be required for preconditioning because cystathionine gamma-lyase inhibition (and thus, attenuation of endogenous H 2 S production) reduces the protective effects of preconditioning. 157, 158 H 2 S appears to protect cells from increased intracellular Ca 2+ overload by accelerating sarcoplasmic reticulum uptake and Na + /Ca 2+ exhange, both of which are protein kinase C dependent. 71 Interestingly, administration of exogenous H 2 S may protect against ischemia-reperfusion via an mTOR-dependent pathway. 159 In addition, H 2 S binds to cytochrome c oxidase, linearly reducing the metabolic rate (as measured by O 2 consumption and CO 2 production) and core body temperature of animals exposed to 0 to 80 ppm. 160 Notably, in mice subject to up to 80 ppm H 2 S, complete reversal of this "suspended animation-like state" is possible with no observed deficits in function or behavior. 160 Furthermore, administration of H 2 S (via Na 2 S, an H 2 S donor) before reperfusion leads to a reduction in inflammation, preservation of mitochondrial structure, and reduced infarct size after myocardial ischemia. 161 Although gaseous administration of H 2 S is challenging, development of H 2 S-generating agents is underway (eg, NaHS). Multiple authors have demonstrated a significant reduction in myocardial infarct size when NaHS is administered before the onset of ischemia. 162, 163 The mechanisms of preconditioning are multiple but may include antioxidant (including nuclear localization of Nrf2), antiapoptotic (related to opening of mitochondrial K ATP channels), and anti-inflammatory activity. 83 CO, long known for its potential toxicity resulting from its inhibitory effects on the cytochrome c oxidase, is also produced endogenously by the heme oxygenase family of enzymes. Heme oxygenase 1 and 2 (HO-1 and HO-2) degrade hemoglobin into CO and biliverdin, the latter of which is rapidly converted to bilirubin, an important antioxidant. 83, 164 HO-1 has been shown to protect myocardial tissues from ischemia-reperfusion injury, and it is likely that CO production plays a prominent role in this phenomenon. [165] [166] [167] Although bilirubin can readily scavenge ROS, CO can also impact ROS levels, primarily through its interaction with cytochrome c oxidase (which leads to increased ROS levels), 164 as well as activating antioxidant enzymes, including superoxide dismutase, HO-1, and glutamate-cysteine ligase (which leads to glutathione biosynthesis), referred to as a "pro/antioxidant duality." 168 Interestingly, the cardioprotective effect of HIF-1 in the setting of ROS exposure may be dependent on HO-1 function. 169 The HO-mediated antioxidant properties of carbon monoxide have also been demonstrated in a porcine model of central nervous system injury (seizure;
170 Figure 6 , adapted from Eltzschig and Eckle
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). Despite the fact that it inhibits cytochrome c oxidase, CO may, in some circumstances, actually increase ATP levels. 167, [172] [173] [174] Although the mechanism for this counterintuitive phenomenon has not been clarified, it is interesting to note that CO can lead to increases in HIF-1α expression. 175 Also worth noting is that although CO binds to cytochrome c oxidase, it has much greater affinity for hemoglobin and myoglobin. 176 This raises the possibility that low-dose CO may lead to a "pseudohypoxic" state, in which cells sense and respond to "hypoxia" when oxygen supplies are adequate. 167 In addition to potential protection from ROSmediated injury as well as increased ATP production (at low levels of exposure), CO exerts anti-inflammatory effects primarily through mitogen-activated protein kinase pathways (in particular, p38 mitogen-activated protein kinase), 164 modulates apoptosis, 167 and induces mitochondrial biogenesis. 177 Exposure to CO either directly (gaseous form) or via a CO releasing molecule (eg, carbon monoxide releasing molecule-3) has been shown to reduce inflammation and improve mortality in a variety of sepsis models. 172, 173, [177] [178] [179] [180] [181] Similarly, in pigs exposed to cardiopulmonary bypass (which elicits a profound proinflammatory response), exposure to CO improves myocardial energetics, increasing ATP availability and decreasing apoptosis after cardioplegic arrest (Table) . 174 H 2 has been shown to protect cultured cells against hydroxide exposure, and inhalation of H 2 has been shown to attenuate ischemia-reperfusion injury in rats subjected to middle cerebral artery occlusion as well as reduce oxidative stress in rats subjected to experimental subarachnoid hemorrhage. 182, 183 Unlike other potentially therapeutic gases, H 2 is not produced endogenously.
HIF and PHD Inhibitors
A variety of antineoplastic agents have been developed to inhibit HIF-1α-related transcription, protein translation (and degradation), or DNA binding. Particularly promising agents include YC-1 (which inhibits expression of HIF-1α by interfering in a variety of HIF-1α mediated activities and has been demonstrated to arrest cell cycling and lead to apoptosis in cancer cells), and ENMD-1198 and PX-478 (both of which also inhibit HIF-1α at multiple levels and are part of the 2-methoxyestradiol analog class of agents that have moved to clinical trials). 184 In general, these agents have great antineoplastic potential with less cytotoxicity than traditional agents.
HIF inhibitors seek to prevent cancerous cells from adapting to hypoxia. HIF prolyl hydroxylases (PHDs) degrade HIF-1α during normoxia, preventing expression of HIF-1α--regulated genes (which improve tolerance to hypoxia and ROS, in addition to mediating preconditioning). The goal of PHD inhibition is to prevent the development of a hypoxic environment conducive to cancer cell survival and metastasis. From an antineoplastic perspective, the main interest in PHD inhibition is in the potential to alter the vascular endothelium by inducing "vascular normalization" and angiogenesis, both of which prevent the development of a hypoxic environment that encourages tumor growth. [185] [186] [187] [188] Outside of the oncologic environment, expression of HIF-1α without exposure to hypoxia or ischemia could potentially produce the beneficial effects of HIF-1α upregulation on cell survival without incurring the risks associated with hypoxia or ischemia. For instance, inhibition of PHDs has been shown to attenuate ischemia-reperfusion injury in both renal and myocardial tissue in mice. 77, 189 PHD inhibitors are now under development for humans, and they appear to be well tolerated. 190, 191 Injection of the HIF-stabilizing agent www.anesthesia-analgesia.org
ANESTHESIA & ANALGESIA cobalt chloride (CoCl 2 ) has also been shown to decrease tissue injury in an animal model of ischemia and reperfusion.
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Peroxisome Proliferator-Activated Receptors Activation
As described above, peroxisome proliferator--activated receptors α (PPARα) mediates the metabolic switch that accompanies the HIF-mediated response to hypoxia. Administration of the PPARα agonist fenofibrate to mice improved their tolerance to hypoxia. 192 Similarly, administration of the PPARα/δ agonist T33 reduced infarct size after middle cerebral artery occlusion in rats. 193 Administration of the PPARγ agonists rosiglitazone and pioglitazone (but not WY-14643, a PPARα agonist) has been shown to reduce mortality in rodents subjected to sepsis. 194, 195 Like PPARα, PPARγ modulates metabolism and is upregulated by HIF-1 in the setting of hypoxia. 196 
NEXT STEPS AND CLINICAL APPLICATION
More widespread use of broadband NIRS and the PpIX-TSLT in the studies of humans could clarify much of the confusion about the role of lactate and subcellular alterations in a variety of critically ill or perioperative patient populations. The mortality rate of sepsis remains disturbingly high, [197] [198] [199] [200] and advanced diagnostic techniques combined with targeted therapeutics may offer the ability to identify and correct subcellular derangements that were previously misunderstood, undiagnosed, and untreated. Given their favorable riskbenefit profile and relatively low cost, preconditioning and exercise training deserve additional investigation in prospective, clinical trials. Therapeutic gases, HIF-1α and PHD inhibitors, and PPARα activators will likely need additional translational work before being tested in humans.
Although the 30-day mortality for perioperative patients is considerably lower than in sepsis, 201 for specific patient populations, the ability to better monitor and manage subcellular energetics might still be useful. Spinal cord paralysis after thoracic aortic surgery, kidney injury after cardiac surgery, and cerebral dysfunction after deep hypothermic circulatory arrest all pose substantial risks in patients undergoing these high-risk surgical procedures. [202] [203] [204] [205] The ability to prepare for, detect, and actively manage organ injury could be lifesaving in these and other at-risk populations.
CONCLUSIONS
P
31 NMR has provided researchers with significant insight into intracellular pH and high-energy phosphate levels during a variety of pathologies including sepsis, but it is clinically impractical. Measurement of serum lactate can provide insight into activity of anaerobic metabolic pathways, but it is not organ-specific, and larger trials are needed to assess the utility of this simple, noninvasive measurement technique. NIRS allows researchers to measure the oxidation state of cytochrome aa 3 , a critical component of the ETC, in real time. The PpIX-TSLT allows researchers to measure mitochondrial oxygen tension. These latter 2 techniques may yield additional insight into the mechanisms leading to subcellular energetic disarray, in addition to some day providing a useful clinical monitor, and have significant clinical potential. Recent findings in subcellular energetics implicate HBO therapy, preconditioning, exercise training, therapeutic gases, HIF and PHD inhibitors, and PPAR inhibition as potential treatment modalities in a variety of pathologic conditions for which current treatment strategies are only marginally successful (eg, sepsis, ischemia, and cancer). E ACKNOWLEDGMENTS I would like to acknowledge my colleague, Dr Marcel E. Durieux, for his thoughtful, constructive, and unbiased critique of this article during the peer review process, as well as to my mentors, Drs Zhiyi Zuo, at the University of Virginia, and Dr Claude Piantadosi, at Duke University. . Ischemia leads to inflammation, tissue injury, and ROS production, which, when coupled with reperfusion, can lead to injury. Gaseous transmitters now known to be produced endogenously (eg, CO, NO) may have the ability to modify the response to ischemiareperfusion injury at various points along the pathway to injury. 
